Add like
Add dislike
Add to saved papers

Risk factors of lymph node metastasis in patients with non-small cell lung cancer ≤ 2 cm in size: A monocentric population-based analysis.

Thoracic Cancer 2018 January
AIM: This study was designed to determine the risk factors of lymph node metastasis in non-small cell lung cancer (NSCLC) patients with tumors ≤ 2 cm, using the Shanghai Chest Hospital Lung Cancer Database.

METHODS: Five hundred and eighteen patients with NSCLC ≤ 2 cm were included in this study, and were classified into lymph node-positive and lymph node-negative groups. Univariate and multivariate logistic regression analyses were performed to select the independent risk factors for lymph node metastasis in NSCLC patients.

RESULTS: No evidence of metastasis was found in tumors ≤ 1 cm, all positive results were in tumors sized 1-2 cm. Imaging characteristics, including solid and part-solid nodules, were strongly associated with lymph node metastasis (odds ratio [OR] 24.959, 95% confidence interval [CI] 5.999-103.835, P < 0.001; OR 12.559, 95% CI 3.564-44.259, P < 0.001) and subgroup logistic analysis (OR 21.384, 95% CI 5.058-90.407, P < 0.001; OR 11.632, 95% CI 3.290-41.126, P < 0.001). Greater lymph node metastasis was observed in non-adeno non-squamous carcinoma. The presence of pleural invasion and carcinoembryonic antigen levels indicated lymph node dissection. Similar results were revealed in subgroup analysis in tumors ≤ 2 to > 1 cm.

CONCLUSION: Size had a great impact on lymph node metastasis, especially tumors of 1-2 cm. Preoperative imaging, non-adeno non-squamous carcinoma, pleural invasion, and carcinoembryonic antigen all indicated lymph node dissection. There was no discrepancy between N1 and N2 positive lymph nodes.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app